New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis.
about
Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitorsmicroRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity.Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene.Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer.The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistanceSelective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast CancerEthinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study.Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer.Carcinogenesis explained within the context of a theory of organisms.The estrogen receptor alpha-derived peptide ERα17p (P(295)-T(311)) exerts pro-apoptotic actions in breast cancer cells in vitro and in vivo, independently from their ERα status.The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory
P2860
Q34082909-ED158267-FD01-433F-B86A-81D2A881267EQ34374980-FD607CB7-9294-4A54-A792-238EC40519EFQ34896573-7F8D0631-0C2D-4D74-8C57-F41E07AAF4DFQ35582486-0C7F70B0-E2EA-4A6E-BA63-B1C7F938C20DQ35939435-F94B8395-844C-4D50-A058-6AB801938E6EQ36656704-A878AA05-C237-4C96-8158-A9C85039CB6BQ37182310-85E2F2D6-BED9-4C0C-AFD0-E9B4D482F7EDQ38352305-3BF14A3E-AA1F-4E77-B61E-1672345FAE8DQ38920835-A03F5AB1-1AB6-43F6-B96E-AB6EB8D0340EQ39619285-17752215-740E-45C0-B6D8-D7BD1238BB41Q41789765-CF45EE83-7405-48A2-8A61-8F7DBC2044CE
P2860
New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
New hypotheses and opportuniti ...... f oestrogen-induced apoptosis.
@ast
New hypotheses and opportuniti ...... f oestrogen-induced apoptosis.
@en
type
label
New hypotheses and opportuniti ...... f oestrogen-induced apoptosis.
@ast
New hypotheses and opportuniti ...... f oestrogen-induced apoptosis.
@en
prefLabel
New hypotheses and opportuniti ...... f oestrogen-induced apoptosis.
@ast
New hypotheses and opportuniti ...... f oestrogen-induced apoptosis.
@en
P2093
P2860
P1433
P1476
New hypotheses and opportuniti ...... f oestrogen-induced apoptosis.
@en
P2093
Eric A Ariazi
Joan S Lewis-Wambi
Roshani R Patel
V Craig Jordan
P2860
P356
10.1016/S0960-9776(09)70266-8
P478
18 Suppl 3
P577
2009-10-01T00:00:00Z